The U.S. continuous renal replacement therapy market size is expected to reach USD 957.2 million by 2028. It is expected to expand at a CAGR of 6.1% from 2021 to 2028. The U.S. market is expected to grow owing to the growing number of ICU patients with Acute Kidney Injury (AKI), along with the increasing incidence of sepsis. Moreover, COVID-19 has positively impacted the market growth. In addition, the presence of well-established key players in the country focusing on developing and commercializing technologically advanced devices and initiatives undertaken by the government to increase the awareness about continuous renal replacement therapy (CRRT) is expected to boost the market growth during the forecast period.
The increasing prevalence of fluid overload, which frequently occurs in AKI patients in critical care units, is a key factor boosting the demand for CRRT devices. Moreover, the FDA has implemented precise laws on manufacturers to endorse the availability of high-quality CRRT devices in ICUs. This is expected to help create lucrative growth opportunities in the U.S. market in the near future.
Leading players such as Baxter International, Inc.; Fresenius Kabi; and Medtronic are investing extensively in R&D to develop technologically advanced CRRT devices. Baxter, for example, has developed a PRISMAFLEX critical care system. It is a versatile platform that provides personalized therapy based on a patient's comfort and suitability. Furthermore, B. Braun's Diapact CRRT system is equipped with modern technology that enables the effective treatment of AKI and kidney disorders. The critical blood filtering process is carried out accurately and without obstructing patients' recovery. Such advancements in CRRT systems, combined with innovation, are expected to result in the increased adoption of CRRT systems, which is anticipated to boost the U.S. CRRT market growth in the near future.
This product will be delivered within 1-3 business days.
The increasing prevalence of fluid overload, which frequently occurs in AKI patients in critical care units, is a key factor boosting the demand for CRRT devices. Moreover, the FDA has implemented precise laws on manufacturers to endorse the availability of high-quality CRRT devices in ICUs. This is expected to help create lucrative growth opportunities in the U.S. market in the near future.
Leading players such as Baxter International, Inc.; Fresenius Kabi; and Medtronic are investing extensively in R&D to develop technologically advanced CRRT devices. Baxter, for example, has developed a PRISMAFLEX critical care system. It is a versatile platform that provides personalized therapy based on a patient's comfort and suitability. Furthermore, B. Braun's Diapact CRRT system is equipped with modern technology that enables the effective treatment of AKI and kidney disorders. The critical blood filtering process is carried out accurately and without obstructing patients' recovery. Such advancements in CRRT systems, combined with innovation, are expected to result in the increased adoption of CRRT systems, which is anticipated to boost the U.S. CRRT market growth in the near future.
U.S. Continuous Renal Replacement Therapy Market Report Highlights
- In terms of product, the liquids segment dominated the market in terms of revenue in 2020. The growing number of manufacturers supplying dialysate and replacement fluids for RRT is contributing to the segment growth
- The disposables product segment is projected to expand significantly during the forecast period owing to the increasing use of hemofilter, fluids, charcoal filters, and other consumables in CRRT treatments
- By modality, in 2020, the Continuous Venovenous Hemodialysis (CVVHD) segment dominated the market in terms of a number of procedures/treatments. The Continuous Venovenous Hemodiafiltration (CVVHDF) segment is expected to expand at the highest volume-based CAGR during the forecast period
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Research Methodology1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 U.S. Market: CAGR Calculation
1.5 U.S. Based Segment Share Calculation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
Chapter 2. Objectives
2.1 Objective - 1:
2.2 Objective - 2:
2.3 Objective - 3:
2.4 Objective - 4:
Chapter 3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
3.3.1 Market Segmentation
3.4 Market Snapshot
Chapter 4. Continuous Renal Replacement Therapy Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Ancillary Market
4.2 Penetration & Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Pipeline Analysis
4.5 Market Dynamics
4.5.1 Market Driver Analysis
4.5.1.1 Increasing Prevalence of Acute Kidney Injury (Aki) and Associated Chronic Kidney Disease
4.5.1.2 Rising Geriatric Population
4.5.1.3 Technological Advancements in Crrt Machines
4.5.1.4 Presence of a Large Number of Hospitals & Dialysis Clinics and Increasing Healthcare Expenditure
4.5.2 Market Restraint Analysis
4.5.2.2 Complications Associated with Usage of Crrt in Critically Ill Neonates
4.5.3 Market Opportunity Analysis
4.5.3.1 Advancements in Crrt Data Management
4.5.4 Market Challenge Analysis
4.5.4.1 Availability of Alternative Therapies
4.6 Continuous Renal Replacement Therapy Market Analysis Tools
4.6.1 SWOT Analysis, by Pest
4.6.2 Porter's Five Forces Analysis
4.7 Major Deals & Strategic Alliances Analysis
4.7.1 Geographical Expansion
4.7.2 Product Launches
4.8 COVID-19 Market Impact
4.8.1 Supply Chain
4.8.2 Changing Market Trends
Chapter 5. Continuous Renal Replacement Therapy Market: Segment Analysis, by Product, 2016 - 2028 (USD Million)
5.1 Definitions & Scope
5.2 Product Market Share Analysis, 2020 & 2028
5.3 Continuous Renal Replacement Therapy Market, by Product, 2015 to 2028
5.4 Market Size Forecasts and Trend Analysis
5.4.1 Crrt System
5.4.1.1 Crrt System Market, 2015 - 2028 (USD Million)
5.4.2 Disposables
5.4.2.1 Disposables Market, 2015 - 2028 (USD Million)
5.4.3 Liquids
5.4.3.1 Liquids Market, 2015 - 2028 (USD Million)
Chapter 6. Continuous Renal Replacement Therapy Market: Segment Analysis, by Modality, 2016 - 2028 (USD Million)
6.1 Definitions & Scope
6.2 Modality Market Share Analysis, 2020 & 2028
6.3 Continuous Renal Replacement Therapy Market, by Modality, 2016 to 2028
6.4 Market Size Forecasts and Trend Analysis
6.4.1 Slow Continuous Ultrafiltration (Scuf)
6.4.1.1 Slow Continuous Ultrafiltration (Scuf) Market, 2016 - 2028 (USD Million)
6.4.2 Continuous Venovenous Hemofiltration (Cvvh)
6.4.2.1 Continuous Venovenous Hemofiltration (Cvvh) Market, 2016 - 2028 (USD Million)
6.4.3 Continuous Venovenous Hemodialysis (Cvvhd)
6.4.3.1 Continuous Venovenous Hemodialysis (Cvvhd) Market, 2016 - 2028 (USD Million)
6.4.4 Continuous Venovenous Hemodiafiltration (Cvvhdf)
6.4.4.1 Continuous Venovenous Hemodiafiltration (Cvvhdf) Market, 2016 - 2028 (USD Million)
Chapter 7. Continuous Renal Replacement Therapy Market: Competitive Analysis
7.1 Company Profiles
7.1.1 Baxter
7.1.1.1 Company Overview
7.1.1.2 Financial Performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic Initiatives
7.1.2 B. Braun Melsungen Ag
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.2.4 Strategic Initiatives
7.1.3 Fresenius Medical Care Ag
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 Medtronic
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 Asahi Kasei Medical Co., Ltd.
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Nipro Corporation
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
List of Tables
Table 1. U.S. continuous renal replacement therapy market, by product, 2016 - 2028 (USD Million)
Table 2. U.S. continuous renal replacement therapy market, by modality, 2016 - 2028 (USD Million)List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. continuous renal replacement therapy market segmentation
Fig. 9 Market summary (2020)
Fig. 10 Market lineage outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Regulatory framework
Fig. 13 Market driver relevance analysis (current & future impact)
Fig. 14 Market restraint relevance analysis (current & future impact)
Fig. 15 U.S. continuous renal replacement therapy market SWOT analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 Continuous renal replacement therapy market: product movement analysis
Fig. 19 Continuous renal replacement therapy market product outlook: Key takeaways
Fig. 20 CRRT systems market, 2016 - 2028 (USD Million)
Fig. 21 Disposable’s market, 2016 - 2028 (USD Million)
Fig. 22 Liquid’s market, 2016 - 2028 (USD Million)
Fig. 23 Continuous renal replacement therapy market: modality movement analysis
Fig. 24 Continuous renal replacement therapy market modality outlook: Key takeaways
Fig. 25 Slow continuous ultra-filtration (SCUF) market, 2016 - 2028 (USD Million)
Fig. 26 Continuous venovenous hemofiltration (CVVH) market, 2016 - 2028 (USD Million)
Fig. 27 Continuous Venovenous Hemodialysis (CVVHD) market, 2016 - 2028 (USD Million)
Fig. 28 Continuous venovenous hemodiafiltration (CVVHDF) market, 2016 - 2028 (USD Million)
Companies Mentioned
- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen Ag
- Baxter
- Fresenius Medical Care Ag
- Medtronic
- Nipro Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 90 |
| Published | November 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 631.2 Million |
| Forecasted Market Value ( USD | $ 957.2 Million |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | United States |
| No. of Companies Mentioned | 6 |
